Toll Brothers stock fell on Tuesday after the luxury-home builder gave weaker than expected guidance for the first quarter next year, while pointing to reports about the slowing housing market as the cause of the housing slowdown.

“In November, we saw the market soften further, which we attribute to the cumulative impact of rising interest rates and the effect on buyer sentiment of well-publicized reports of a housing slowdown,” Toll Brothers chairman and CEO Douglas Yearley said in a statement.

Media reports of a housing slowdown come as U.S. Census data shows new home sales have declined for 11 straight months.

In October, sales of newly built homes fell 12 percent year of year, even as the median price for new homes also dropped. Economists have said the drop in new home sales stems from weakened affordability across U.S. local markets. The housing market has begun showing signs of cracking this year, while realtors are saying that offers for homes have thinned out.

Toll Brothers shares fell 2.8 percent in premarket trading.

Toll Brothers beat top and bottom line estimates for its fourth-quarter earnings report. Two of the homebuilder’s key metrics, deliveries and backlog, were at the highest levels in more than a decade.

However, first quarter guidance from Toll Brothers was weaker than expected, with a deliveries range that was markedly below Wall Street’s expectation, according to FactSet.

Yearley said the company “saw similar consumer behavior beginning in late 2013, when a rapid rise in interest rates temporarily tempered buyer demand before the market regained momentum.” Known as the taper tantrum, rates jumped in 2013 when the Federal Reserve signaled a reduction of money being put into the economy, leading to a surge in mortgage rates. Home sales recovered, however, when mortgages rates fell back again.

Some economists fear this time will be different. Lawrence Yun, chief economist for the National Association of Realtors, said in November that “this time, interests rates are not going down.”

“In fact, they are probably going to increase even further,” added Yun.

Products You May Like

Articles You May Like

Can you save money and the planet by owning a Tesla or another electric car?
FDA orders Boston Scientific, Coloplast to stop selling surgical mesh
This generation is the least frugal with money, and their parents could be partly to blame
Two simple insurance charges you need to understand when choosing health coverage
Tech stocks are best positioned this earnings season, says analyst Nick Colas

Leave a Reply

Your email address will not be published. Required fields are marked *